We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Multiple Pathogens Detected Using Luminescent Nanocrystal Tags

By LabMedica International staff writers
Posted on 14 May 2014
Luminescent nanocrystals and a high-speed scanner enable rapid detection of multiple pathogens in a single test.

A research team using tunable luminescent nanocrystals as tags to advance medical and security imaging have successfully applied them to high-speed scanning technology and detected multiple viruses within minutes. More...
The team previously developed a way to control the length of time light from a luminescent nanocrystal lingers, which introduced the dimension of time in addition to color and brightness in optical detection technology. Detection based on the lifetime of the light from a nanocrystal as well as its specific color, exponentially increases the possible combinations and unique tags that could be created for biomedical screens.

The research, led by Macquarie University (Sydney, Australia) and Purdue University West Lafayette, IN, USA) follows the team's earlier success in developing a way to control the length of time light from a luminescent nanocrystal lingers, which introduced the dimension of time in addition to color and brightness in optical detection technology.

Detection based on the lifetime of the light from a nanocrystal as well as its specific color exponentially increases the possible combinations and unique tags that could be created for biomedical screens.

Yiqing Lu, a researcher at Macquarie University, who led the research explained, "We now are able to build a huge library of lifetime color-coded microspheres to perform multiple medical tasks or diagnoses at the same time. The time saved by omitting the need to grow or amplify a culture sample for testing and eliminating the need to run multiple tests will save future patients precious time so treatment can begin, which can be life-saving when managing aggressive diseases."

The technology could enable screens that identify thousands of different target molecules simultaneously, said J. Paul Robinson, the professor of Cytomics in Purdue's College of Veterinary Medicine and professor in Purdue's Weldon School of Biomedical Engineering, who was involved in the research.

"This is the second part of the puzzle," said Prof. Robinson, who led the biological testing of the technology. "Now [we have] successfully measured the lifetimes of these tags on the fly at thousands of samples per second. The next step is to perform such high-throughput testing within a liquid, like water, blood or urine. That will open the door to widespread biological use and clinical applications, as well as the detection of pathogens in food or water."

Robinson's research focuses on flow cytometry, the analysis of cells that are contained in a liquid flowing past a laser beam. In addition to developing instrumentation to measure the tags, he plans to explore the technology's health care and biodetection applications.

The research team attached unique tags to DNA strands of HIV, Ebolavirus, Hepatitis B virus, and Human Papillomavirus 16. The tags were accurately read and distinguished at high speeds in suspension arrays. The team's work is described online in Nature Communications.

Related Links:

Macquarie University
Purdue University West Lafayette



New
Gold Member
Hematology Analyzer
Medonic M32B
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
New
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: EvoLiver is the first test to receive FDA Breakthrough Device Designation in five years in the liver cancer surveillance space (Photo courtesy of Mursla Bio)

Patient-Friendly Blood Test to Transform Liver Cancer Surveillance

Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is the fastest-growing cause of cancer-related deaths. Although clinical guidelines recommend routine surveillance for high-risk... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.